MN
MediciNova, Inc.
MNOV · NASDAQ
$3.30 +4.10% (+$0.13)
1M +116.99%
Market Cap $163.4M
P/E Ratio -
Div. Yield -
ROE 26.51%
Bulios Fair Price
$3.05
7.6% downside
Trenutna cena
$3.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MNOV trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
23 /100
Expensive P/S 177.53x
P/B 4.38x
P/E N/A
Growth
0 /100
Declining Book val. growth 16.03%
EPS growth N/A
FCF growth N/A
Profitability
17 /100
Weak Gross margin 42.39%
FCF margin 587,172.00%
Net margin 1,168.20%
Quality
0 /100
Poor ROIC 31.54%
Asset turnover 0.02x
ROE 26.51%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 8.75x
Int. coverage N/A
Stability
59 /100
Moderate Beta 0.63x
Profitable years 0
EPS volatility 38.57%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MNOV
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yuichi Iwaki
Employees
6
Headquarters
La Jolla
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report